SEO URLwww.firestrike.ai/deals/optinose-paratek-acquisition-2026
acquisitionAnnounced · Feb 8, 2026PharmaceuticalsSource · Unverified ReportsArticle · Factual
Paratek acquires Optinose
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$330M
Target
Optinose
NASDAQ: OPTN · Yardley, Pennsylvania
Acquirer
Paratek
Full Acquisition
Status
Completed
Paratek agreed to acquire Optinose. Reported deal value: $330M. Status: Completed. Sector: Pharmaceuticals. Target headquarters context: Yardley, Pennsylvania, United States.
This page summarizes publicly available information about the transaction as of 2026-02-08. Figures and status may change as filings and press coverage update.
Foto: über boerse-global.de The acquisition of Optinose by Paratek Pharmaceuticals has been completed , resulting in the company delisting from public markets
Deal timeline
Announced
Feb 8, 2026 · ad-hoc-news.de
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $330M. Figures and status may change as sources update.
Sources: ad-hoc-news.de · Primary article · FireStrike proprietary index